A Slowly Growing Orange Patch on the Cheek: Diagnosis of Lupus Vulgaris 20 Years After Onset of First Skin Changes by Claudia Pföhler et al.
CASE REPORT
A Slowly Growing Orange Patch on the Cheek:
Diagnosis of Lupus Vulgaris 20 Years After Onset
of First Skin Changes
Claudia Pfo¨hler . Michael Klotz . Thomas Wehler . Thomas Vogt .
Cornelia S. L. Mu¨ller
Received: July 21, 2016 / Published online: November 25, 2016
 The Author(s) 2016. This article is published with open access at Springerlink.com
ABSTRACT
Tuberculosis is a worldwide occurring disease
that affects approximately 20–40% of the
world’s population and in particular in
developing countries. However, in times of
migration, industrialised countries are again
being more and more affected. Cutaneous
tuberculosis is rare and lupus vulgaris
represents its most common form.
Preferentially, young adults in developing or
low-income countries are affected from
cutaneous tuberculosis, which usually occurs
in previously sensitized persons with a high
degree of tuberculin sensitivity and a good
immunoresponse. In Europe, more elderly
people are involved. We present a case of
lupus vulgaris that was diagnosed with a delay
of about 20 years after onset of first skin
changes.
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INTRODUCTION
Lupus vulgaris is the most common form of skin
tuberculosis resulting from an infection with
Mycobacterium tuberculosis or M. bovis [1]. Skin
lesions usually affect the face, extremities or
mucous membranes (tongue and lips) and result
from hematogenous, lymphatic or per
continuitatem spread of organ tuberculosis [2].
In rare cases, exogenous inoculation can be
causative. In Europe, lupus vulgaris is
characteristically a disease of elder people,
whereas in developing countries younger
persons are mostly concerned. Cases of lupus
vulgaris due to M. bovis bacillus
Calmette–Gue´rin (BCG) at the sites of previous
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BCG vaccination have been reported [2, 3].
Infections with M. bovis ssp. bovis or M. bovis
ssp. caprae usually result from direct contact
with infected animals or consumption of
nonpasteurised milk products from dairy cattle
[4].
CASE REPORT
A 56-year-old female patient, who had been
living in Saarland, south-west Germany, since
birth, presented first in 2012 with an almost
20-year history of an orange, painless, slowly
growing skin infiltrate on her right cheek
(Fig. 1a). She was referred by her general
practitioner who had documented the first skin
lesions 19 years ago which he had rated as
chronic eczema. In 2012, a skin biopsy was
recommend but not performed as the patient
refused further diagnostic procedures and
therapy. She presented again in 2015 and
reported that the skin lesion on the cheek had
been growing centrifugally (Fig. 1b). The lesion
measured more than 10 cm in diameter, showed
central atrophy and elevated and scaling borders.
Diascopy demonstrated a lupoid, apple jelly-like
infiltrate. The earlobe was also affected and
mutilated. Skin biopsies from the center and
from the border of the lesion showed an
unaffected epidermis with some parakeratosis.
Fig. 1 Skin changes in 2012 when the patient refused
further diagnostic procedures (a). Skin lesions in early
2015 prior to therapy (b). Improvement of lupus vulgaris
after 6 weeks of antibiotic treatment (c). Complete healing
after 1 year of therapy (d)
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In the dermis, multiple granulomas were present
besides epithelioid histiocytes and giant cells
with multiple nuclei (Fig. 2a, b). Necrosis and
fibroblastic activity could be detected in the
center of some of the granulomas (Fig. 2a, b).
Ziehl–Neelsen stain showed groups of acid-fast
bacilli (Fig. 2c). Conventional culture of fresh
biopsy material time-delayed proved
Mycobacterium bovis spp. bovis (Geno Type
MTBDR by PCR analysis) whereas direct
microscopy and the polymerase chain reaction
of Mycobacterium complex-specific DNA
sequences were negative. The standard
QuantiFERON test used as an interferon-gamma
release assay to detect a latent tuberculosis was
initially negative, even though PPD-specific
CD4? T cells were detectable in a separate
assay. A Mendel–Mantoux test as a tuberculin
skin test could not be performed as this test is no
longer available in Germany. The search for
organ tuberculosis was negative with
inconspicuous results in chest X-ray, CT scan of
the thorax, bronchoscopy and bronchoalveolar
lavage. In conclusion, the diagnosis of lupus
vulgaris without systemic involvement was
established. Treatment was initiated with
isoniazid (300 mg per day), rifampicin (600 mg
per day), pyrazinamide (1750 mg per day) and
ethambutol (1400 mg per day) at the time of
histological confirmation of lupus vulgaris. At
that time, the results from conventional culture
of fresh tissue material was still outstanding.
Six weeks later, an improvement of skin
infiltration and incipient healing could be
observed (Fig. 1c). In the case of M. bovis
(Genotype MTBDR), an intrinsic resistance to
pyrazinamide must be presumed. However, if an
adequate response to therapy can be
documented, as in the case presented here, an
induction therapy consisting of isoniazid,
rifampicin and ethambutol is appropriate. After
completion of the induction therapy, an
extended maintenance regimen should be
continued for a total period of 1 year.
Treatment was performed that way in our case
and led to complete healing of the lupus vulgaris
(Fig. 1d). Additional informed consent was
obtained from the patient for whom
identifying information is included in this
article.
DISCUSSION
Bovine tuberculosis was a common infection in
cow in the 1950s. The infection of humans
occurs through the airways or food intake,
commonly from unpasteurised cow milk [4, 5].
The patient presented here confirmed drinking
unpasteurized cow milk in her childhood. As
she denied any direct contact with cows and
Fig. 2 Histological investigation of a skin biopsy. Dense
subepidermal inﬁltrate of lymphocytic and histiocytic cells
with tuberculoid granulomas and central smaller area of
caseating necrosis. H&E staining, 910 (a). Langerhans
giant cells with multiple nuclei, H&E staining, 940.
Ziehl–Neelsen staining with prove of acid-fast bacilli
within a tuberculoid granuloma (arrow), 960
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calves, the consumption of milk from a Tbc
infected cow is the most likely method of
infection. She reported having never suffered
from organ tuberculosis, and clinical
investigation showed no signs of organ
involvement. She could not remember being
BCG-vaccinated. There was no history of
tuberculosis in her family nor contact with
high-risk persons. It is remarkable that she
presented skin lesions in her face for
approximately 20 years without being
diagnosed with skin tuberculosis, although she
was seen regularly by her general practitioner
due to depression, a poorly controlled diabetes
mellitus type II and hypertension. She reported
that the slowly growing skin lesions on her
cheek had been interpreted as ‘‘a kind of
eczema’’. This was confirmed by her general
practitioner. The skin lesions she presented had
the typical clinical signs of lupus vulgaris with
an orange aspect, and were found in a typical
anatomical site involving the cheek, ear and
neck. Skin biopsy was able to confirm our
tentative diagnosis and culture of fresh biopsy
material proved M. bovis spp. bovis, although
culture of fresh tissue is often negative, as the
PCR diagnostic from paraffin-embedded
specimen often is and indeed was in the case
presented here [6]. The QuantiFERON test as an
interferon-gamma release assay was also
negative, which is a rather common
phenomenon in diabetic patients, who show a
reduced sensitivity to this test [7]. The case
presented here should remind treating
physicians that tuberculosis still remains a
problem in industrialised countries.
CONCLUSION
Skin tuberculosis is often diagnosed years after
the onset of first skin changes. Even in developed
countries such as Germany, treating physicians
should bear in mind that lupus vulgaris has not
disappeared and may still occur, especially in
older European patients. Possibly, in times of
migration, tuberculosis as well as skin
tuberculosis will cause a significant increase in
morbidity in high-income countries which
accommodate large numbers of refugees and
asylum-seekers who have fled from countries in
which tuberculosis is still endemic, such as
Afghanistan, Pakistan or North African
countries like Tunisia [8–11]. In these cases,
predominantly young people are affected.
ACKNOWLEDGEMENTS
No funding or sponsoring was received for this
study or publication of this article. All named
authors meet the International Committee of
Medical Journal Editors (ICMJE) criteria for
authorship for this manuscript, take
responsibility for the integrity of the work as a
whole, and have given final approval of the
version to be published.
Disclosures. Claudia Pfo¨hler, Michael Klotz,
Thomas Wehler, Thomas Vogt and Cornelia S.
L. Mu¨ller have nothing to disclose.
Compliance with Ethics
Guidelines. Additional informed consent was
obtained from the patient for which identifying
information is included in this article.
Open Access. This article is distributed
under the terms of the Creative Commons
Attribution-NonCommercial 4.0 International
License (http://creativecommons.org/licenses/
by-nc/4.0/), which permits any noncommercial
use, distribution, and reproduction in any
medium, provided you give appropriate credit
184 Dermatol Ther (Heidelb) (2017) 7:181–185
to the original author(s) and the source, provide
a link to the Creative Commons license, and
indicate if changes were made.
REFERENCES
1. Bravo FG, Gotuzzo E. Cutaneous tuberculosis. Clin
Dermatol. 2007;25(2):173–80.
2. van Zyl L, du Plessis J, Viljoen J. Cutaneous
tuberculosis overview and current treatment
regimens. Tuberculosis (Edinb). 2015;95(6):629–38.
3. Walker SL, Lozewicz S, Sood R, Mann TA,
Campalani E, Hubbard VG. Lupus vulgaris due to
Mycobacterium bovis bacillus Calmette–Guerin (BCG)
at the site of previous BCG vaccination. Clin Exp
Dermatol. 2009;34(7):e213–5.
4. Tar SY, Bozdemir B, Gurel MS, Bilgin FU, Baran MF,
Demirkesen C. Mycobacterium bovis caprae: a rare
agent of lupus vulgaris. Clin Exp Dermatol.
2009;34(4):532–3.
5. Meyer S, Naumann L, Landthaler M, Vogt T. Lupus
vulgaris caused by Mycobacterium bovis ssp. caprae.
Br J Dermatol. 2005;153(1):220–2.
6. Marchetti G, Gori A, Catozzi L, Vago L, Nebuloni M,
Rossi MC, et al. Evaluation of PCR in detection of
Mycobacterium tuberculosis from formalin-fixed,
paraffin-embedded tissues: comparison of four
amplification assays. J Clin Microbiol.
1998;36(6):1512–7.
7. Choi JC, Jarlsberg LG, Grinsdale JA, Osmond DH,
Higashi J, Hopewell PC, et al. Reduced sensitivity of
the QuantiFERON((R)) test in diabetic patients with
smear-negative tuberculosis. Int J Tuberc Lung Dis.
2015;19(5):582–8.
8. Abdelmalek R, Mebazaa A, Berriche A, Kilani B, Ben
Osman A, Mokni M, et al. Cutaneous tuberculosis
in Tunisia. Med Mal Infect. 2013;43(9):374–8.
9. Bua A, Cubeddu M, Piras D, Delogu R, Zanetti S,
Molicotti P. Tuberculosis screening among asylum
seekers in Sardinia. J Public Health (Oxf). 2016.
doi:10.1093/pubmed/fdv215.
10. Ibrahim KM, Khan S, Laaser U. Tuberculosis
control: current status, challenges and barriers
ahead in 22 high endemic countries. J Ayub Med
Coll Abbottabad. 2002;14(4):11–5.
11. Pareek M, Greenaway C, Noori T, Munoz J, Zenner
D. The impact of migration on tuberculosis
epidemiology and control in high-income
countries: a review. BMC Med. 2016;14:48.
Dermatol Ther (Heidelb) (2017) 7:181–185 185
